Publicaciones - ONCOLOGÍA CLÍNICA Y TRASLACIONAL

Cargando...

Alonso-Romero JL, Martinez-Garcia J, Carrillo-Vicente R, Aramburo AF, Diez AF, Henarejos PS, de la Morena Barrio P, Boix AP, Jimenez MD, Siles JP, Maestre JAP, de Las Heras-Rubio A, Carreno PR. Translational and real-world evidence of trastuzumab biosimilar CT-P6 plus pertuzumab in neoadjuvant HER2-positive early breast cancer. Breast Cancer Res Treat. 2026 Jan 20;215(2):60. doi: 10.1007/s10549-026-07895-8. PubMed PMID: 41557021; PubMed Central PMCID: PMC12819485.

AÑO: 2026; IF: 3.0

41557021

Mas Bermejo C, Mas Gomez C, Sevilla-Garcia MA, O'Connor-Reina C, Falardo Ramos S, Alonso-Romero JL, Bravo-Gonzalez LA. Restoring Physiological Normoxia as an Adjuvant Strategy to Improve Cancer Treatment Outcomes. Nat Sci Sleep. 2026 May 19;18:593331. doi: 10.2147/NSS.S593331. eCollection 2026. PubMed PMID: 42199305; PubMed Central PMCID: PMC13199069.

AÑO: 2026; IF: 3.4

42199305

Hurvitz SA, Layman RM, Curigliano G, Andre F, Cristofanilli M, Kim SB, Martinez Rodriguez JL, Nadal JC, Kim GM, Lo L, Remolina-Bonilla YA, Rosselli G, Emile G, Korbenfeld E, Puig JM, Wesolowski R, Martin M, Ring A, Han HS, Giordano A, Mutka SC, Moss K, Suzuki S, Sullivan B, Gorbatchevsky I, Pistilli B; VIKTORIA-1 Study Group. VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer. J Clin Oncol. 2026 Apr 20;44(12):1108-1119. doi: 10.1200/JCO-25-02643. Epub 2026 Mar 9. PubMed PMID: 41802242; PubMed Central PMCID: PMC13075786.

AÑO: 2026; IF: 41.9

41802242

Fernandez O, Molina A, Anido-Herranz U, Alvarez C, Girones R, Gajate P, Dominguez RG, Ros S, Puente J, Blasco S, Ore-Arce M, Martinez EN, Fernandez-Freire A, Del Pozo N, Cassinello J, Lazaro-Quintela M, Arranz F, Crespo G, Abad MT, Llorente M, Sanchez-Hernandez A, Juan MJ. Real-world data on avelumab in first-line maintenance therapy for advanced or metastatic urothelial carcinoma: the SOGUG-AVELUMAB RWD study. Clin Transl Oncol. 2026 Jan;28(1):254-264. doi: 10.1007/s12094-025-03978-y. Epub 2025 Jul 9. PubMed PMID: 40629216; PubMed Central PMCID: PMC12790522.

AÑO: 2026; IF: 2.5

40629216

Encarnacion JA, Dominguez-Gil B, Pellicer C, Fernandez R, Moya J, Ortin A, Manso C, Fernandez M, Lucas C, Jimena R, Lopez N, Alonso-Romero JL, Ruiz P, Ortega-Lopez ND, Royo-Villanova M. Midazolam prescription as a trigger for potential deceased donor identification outside the ICU: a prospective feasibility study. BMC Palliat Care. 2026 May 29. doi: 10.1186/s12904-026-02163-4. Online ahead of print. PubMed PMID: 42215950.

AÑO: 2026; IF: 3.0

42215950

Siguiente >

Publicaciones - ONCOLOGÍA CLÍNICA Y TRASLACIONAL

Instituto de Investigación Sanitaria Acreditado

ONCOLOGÍA CLÍNICA Y TRASLACIONAL